Hydroxychloroquine Inhibits Cardiac Conduction in Aged Patients with Nonmalaria Diseases

BACKGROUND: The COVID-19 pandemic has brought increased focus on hydroxychloroquine (HCQ), as doctors, the medical community, and policymakers around the world attempt to understand how the risks of HCQ weigh against unknown benefits. We aim to evaluate the effects of HCQ on cardiac conduction, thus...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Kidney Dis (Basel)
Asıl Yazarlar: Yu, Yanting, Xu, Jianteng, Xie, Anni, Liu, Sijia, Wang, Xiaojian, Zhu, Runzhang, Wang, Xiaoyan
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: S. Karger AG 2021
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8089424/
https://ncbi.nlm.nih.gov/pubmed/34192120
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000515278
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller